Besides being an Analyst on both the Buyside and Sellside, the author has worked in Corporate Strategy and Finance roles for technology services companies and has now been publishing risk-adjusted, return-driven, quantitative model portfolios for many years at Graycell Advisors. More ... more

Besides being an Analyst on both the Buyside and Sellside, the author has worked in Corporate Strategy and Finance roles for technology services companies and has now been publishing risk-adjusted, return-driven, quantitative model portfolios for many years at Graycell Advisors. More can be learned about the author here.

For the year 2016, the Graycell Small Cap Portfolio was up +71% compared to benchmark Russell 2000 Index gain of +19%. In addition, the Prudent Biotech Portfolio was up +7%, compared to the Nasdaq Biotech Index (IBB) decline of -21% in 2016

You are invited to take a look at our website for Samples, Performance, Philosophy, and Approach and decide if the Biotech and Small Cap products can contribute to your investment objectives.

You can even Register for a Free Monthly Pick direct from the Portfolio, 

All subscriptions come with a Risk-free, 60-Day Money-back Guarantee.

Any questions, please write to Support @ GraycellAdvisors .com or use the Contact Form.

Graycell Advisors and related entities are not a Registered Investment Advisor (RIA). Nothing here or on the site constitutes a personalized investment recommendation, and stocks mentioned in the reports/articles/comments may be now or in the past, part of the portfolios recommended by Graycell Advisors and related entities. All opinions expressed are subject to change as new information develops, and no updates will be provided on model portfolios unless you are a subscriber.